发明名称 |
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases |
摘要 |
A method administers quaternary ammonium anti-cholinergic muscarinic receptor antagonists in combination with acetyl-cholinesterase inhibitors to treat either cognitive impairment or acute delirium. This therapy results in a modification of a cognitive disorder or disease, namely a slow down in the disease progression. In one preferred embodiment, the disease is dementia with Lewy Bodies. New formulations for quaternary ammonium anti-cholinergic muscarinic receptor antagonists are also disclosed. |
申请公布号 |
US8969402(B2) |
申请公布日期 |
2015.03.03 |
申请号 |
US201313778530 |
申请日期 |
2013.02.27 |
申请人 |
|
发明人 |
Rich Steven A. |
分类号 |
A01N43/36;A61K31/40;A01N43/40;A61K31/445;A01N47/10;A61K31/27;C07D207/00;A61K31/137;A61K31/216;C07D207/12;C07D451/00;A61K31/435;A61K31/4015;A61K31/438;A61K31/165;A61K31/407 |
主分类号 |
A01N43/36 |
代理机构 |
Brown & Michaels, PC |
代理人 |
Brown & Michaels, PC |
主权项 |
1. A method for altering a disease progression of dementia with Lewy Bodies comprising administering to a patient a therapeutic amount of glycopyrrolate and a therapeutic amount of rivastigmine. |
地址 |
|